Hasil Pencarian

✨ 7 results found - Searched 21220 records in 3ms.
cover

Tesis

Proporsi pneumonia pada pasien kanker paru yang datang ke IGD RSUP Persahabatan
2024 | BY HEidy Agustin - Sita Laksmi Andarini - Budi Haryanto - Muhammad Nurman Ariefiansyah
  • Proportion of pneumonia in lung cancer patients who come to emergency instalation at Persahabatan Hospital.
  • Nomor Panggil T24269fk
cover

Tesis

Proporsi ekspresi programmed death ligand-1 (PD-L1) pada neoplasma neuroendokrin paru di Rumah Sakit Umum Pusat Persahabatan
2023 | BY Andika Chandra Putra - Sita Laksmi Andarini - Romi Beginta - Gigih Setiawan
  • The proportion of programmed death ligand-1 (PD-L1) expression in lung neuroendocrine neoplasms at Persahabatan General Hospital.
  • Nomor Panggil T23581fk
cover

Tesis

Proporsi gambaran penyakit paru interstisial pada pasien kanker paru karsinoma bukan sel kecil dengan terapi epidermal growth factor receptor tyrosine kinase inhibitor di RSUP Persahabatan
2023 | BY Marscha Iradyta Ais - Sita Laksmi Andarini - Dianiati Kusumo Sutoyo - Maryastuti
  • The proportion of interstial lung disease features in patients with non small cell lung cancer treated with epidermal growth factor receptors tyrosine kinase inhibitor at Persahabatan Hospital.
  • Nomor Panggil T23187fk
cover

Tesis

Prevalens Penyakit Paru Obstruksi Kronik (PPOK) dan Emfisema Berdasarkan Pemeriksaan Spirometri dan Computed Tomography Scanning (CT-scan) Toraks Pada Pasien Kanker Paru di Rumah Sakit Umum Pusat Persahabatan
2019 | BY Prima Belia Fathana - Faisal Yunus - Sita Laksmi Andarini - Aziza G. Icksan
  • Prevalence of Chronic Obstructive Pulmonary Disease and Emphysema Based on Spirometry and Thorax CT-scan among Lung Cancer Patients Treated at Persahabatan Hospital Jakarta, Indonesia.
  • Nomor Panggil T19279fk
cover

Tesis

Efikasi dan Toksisiti Erlotinib/Gefitinib sebagai Terapi Lini Kedua Pada Pasien Kanker Paru Jenis Karsinoma Bukan Sel Kecil
2015 | BY Sita Laksmi Andarini - Jamaluddin M. - Achmad Hudoyo
  • Efficacy and Toxicity Erlotinib/Gefitinib as Second Line Therapy in Non-Small Cell Lung Cancer Patients.
  • Nomor Panggil T 15 543 FK
cover

Tesis

Peran quiescent lung cancer stem cell (CSC) dalam proses resistans terhadap agen epidermal growth factor receptortyrosine kinase inhibitor (EGFR-TKI) pada adenokarsinoma paru dengan mutasi EGFR positif
2020 | BY Moulid Hidayat - Sita Laksmi Andarini - Fumiyuki Takahashi
  • Role of quiescent lung cancer stem cells in epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR- TKI) resistance in EGFR-mutant lung adenocarcinoma.
  • Nomor Panggil T20481fk